Chapter 4

Category and Moat

The pasture-raised egg category is a genuine, durable tailwind, and Vital Farms still leads it. Measured by volume rather than by inflated retail dollars, pasture-raised has been the fastest-growing corner of the egg aisle for five years — and it kept growing in 2026 even as commodity egg prices collapsed. But leadership is loosening: the company's own disclosed share of the pasture-raised segment fell from roughly 90% to just over half in three years, and it stopped publishing the figure. The moat is the farm network and the brand, not ownership of the category.

The tailwind is real, and it is a volume story

Vital Farms sells into a category that is expanding fast on every measure the filings offer. Per Circana data in the FY2025 10-K, U.S. pasture-raised retail sales reached roughly $1.3 billion in 2025, compounding at 37.5% a year since 2021; the broader specialty-egg market (pasture-raised plus free-range) was about $12.6 billion at a 26.4% CAGR, against a total shell-egg market of $15.4 billion growing 21.3% [1]. Those dollar growth rates flatter the story, because the same avian-flu spike that ran through this report's earlier chapters lifted the price of every egg in the count. The cleaner read strips price out and looks at volume.

On a volume basis the category ranking is unambiguous. The company's December 2025 Investor Day put five-year segment volume CAGRs side by side: pasture-raised grew 27% a year from 2020 to 2025, free-range and cage-free each 12%, while conventional eggs — still the overwhelming majority of the market — shrank 6% [2].

Source: December 2025 Corporate Presentation (Investor Day), egg category volume growth rates [3].

The most direct test of whether the shift is secular or was merely a flu-price windfall came in the first quarter of 2026, when conventional eggs were the cheapest they had been in years. Management reported that premium "outdoor access" eggs — free-range and pasture-raised combined — had grown from 8% of category volume in 2023 to 15% by early 2026, and that year-to-date those eggs were growing 32% in volume against 4% for mainstream eggs, "despite the lowest price in years" [4]. The tailwind, in other words, did not reverse when the cyclical price gap did. That is the load-bearing point for the through-line: the category the reset thesis depends on is still compounding, and Vital Farms' problem in 2026 was not a shrinking pond.

The runway is also still long. Vital Farms' shell eggs reached about 10.5% of U.S. households in 2025 — up from 3.6% at the 2020 IPO — against category household penetration near 97% [5]. Nine in ten American households buy eggs; barely one in ten yet buys this brand.

The moat shows up in the farm network and the shelf

Vital Farms remains the number-one U.S. pasture-raised brand, the number-one natural-channel egg brand, and the number-two U.S. egg brand of any kind by retail dollar sales [6]. The question a professional investor should press is whether that position rests on anything a well-funded competitor cannot simply buy. Two things pass the test; one is more fragile than the brand's ranking suggests.

The first is the supply chain. Vital Farms sources from a network of more than 600 small family farms concentrated in the "Pasture Belt," the region where hens can be kept outdoors year-round [7], and it describes this as "one of the largest sourcing and distribution networks of family farms" it believes it operates [8]. The network is contractually locked: buy-sell contracts covered all of the laying hens in the network at year-end 2025 [9]. Recruiting a farmer is not cheap or quick for a rival, either: the company requires each contracted farm to build and equip to its specifications, "which requires a significant upfront capital investment" [10]. Feeding that network into scale is Egg Central Station, the company's owned processing plant in Missouri, capable of packing more than 7.5 million eggs a day [11]. A competitor can build a plant; assembling hundreds of certified pasture farms under contract is the slower part.

The second is the brand, and it shows up in numbers rather than adjectives. Even through the 2026 price shock, existing buyers did not leave: units per retained household ran 2% above the prior eight-quarter average, and consumers "generally resisted trading down to lower priced alternatives" [12]. Shelf productivity has long been the brand's calling card — at the IPO the company sold at roughly $241 per store per item per week in the natural channel against $110 for all other egg brands [13] — and retailers are still expanding placements: the company's total distribution points rose to about 150 exiting Q1 2026 from 116 a year earlier, with management guiding toward 170–175 by year-end, its best distribution year since going public [14]. Retention held and shelf space grew during the worst quarter of the cycle. That is the moat doing its job.

Leadership of the category is narrowing

The fragile part is share. As the category grew, Vital Farms' grip on it slipped — visibly, in its own disclosures, until the disclosure stopped.

Sources: Vital Farms 10-Ks FY2021 [15], FY2022 [16], FY2023 [17], FY2024 [18] and FY2025 [19].

The company reported an 88% share of the U.S. pasture-raised retail egg market in 2021 [20], over 90% in 2022 [21], over 85% in 2023 [22], and just over 54% in 2024 [23]. The FY2025 10-K dropped the share figure entirely, keeping only the "#1" ranking [24].

Two caveats keep this from being a clean 90-to-54 collapse. The data provider changed from SPINS to Circana between the 2023 and 2024 disclosures, the phrasing shifted from "market" to "segment," and the measured category itself nearly doubled in dollars over the same window ($531 million to $994 million), so part of the apparent drop reflects a bigger, differently-defined denominator rather than lost cartons. But the direction is not in doubt, and a company that had trumpeted a 90% share for years does not quietly stop disclosing it while gaining ground. The honest read is that Vital Farms is still the clear leader of pasture-raised, but no longer close to the whole of it.

Who took the rest is the more useful question, and the FY2026 commentary answers it more precisely than the 10-K's competition paragraph. The price gap that actually stalled Vital Farms' velocity in 2026 was not the gap to conventional eggs — it was the gap to other premium eggs. Management described bringing one top-10 customer's price premium down "from about 35% above a group of competing premium branded outdoor access eggs to about 25%," after which volumes rose 18% in two weeks [25]. The competition is now intramural: other branded outdoor-access eggs and private-label pasture-raised lines, not caged commodity eggs. That is a meaningful refinement of the surge-and-stall mechanism laid out in The Egg Premium — the sensitive variable is Vital Farms' premium over its premium rivals, a gap a rival can widen by pricing down.

Behind that pressure sits a competitor with resources Vital Farms cannot match. The company names Cal-Maine Foods as a competitor in its own filing [26]. Cal-Maine is the largest U.S. egg producer, with roughly $2.9 billion of net sales in its fiscal 2026 (year ended May 2026) — about four times Vital Farms' revenue [27].

Sources: pasture-raised category and VITL — FY2025 10-K [28]; Cal-Maine net sales — CALM FY2026 10-K [29].

More important than the size gap is what Cal-Maine is doing with it. Its stated growth strategy prioritizes expanding specialty shell-egg capacity — the classification under which it books pasture-raised eggs [30]. It already owns the Egg-Land's Best and Land O'Lakes branded specialty lines — Egg-Land's Best was the third best-selling dairy brand in the U.S. in 2025 [31] — and it buys its way into more capacity relentlessly: 28 acquisitions since 1989, including Echo Lake Foods ($289.5 million), Creighton Brothers ($129.3 million), ISE America and Clean Egg all closed in its FY2025–FY2026 [32]. This is the well-funded competitor the moat test asks about, and it is actively adding the one asset — specialty and pasture capacity — that would let it press Vital Farms' premium.

The read

The category is not the risk; it is the opportunity, and it is durable. Pasture-raised has out-grown every alternative by volume for five years and kept growing when the flu-driven price prop fell away, and Vital Farms sits at 10.5% household penetration in a category that reaches nearly every home — a long runway on a real secular shift. The risk is the second-order consequence of leading a fast-growing category: it draws capital and competitors. Vital Farms' defensible assets — the contracted family-farm network and a brand that retains its buyers and wins shelf space — are hard to copy quickly and are the reason to expect it to keep growing volumes. What those assets do not defend is share of the category or the size of the premium, both of which are already compressing.

The strongest fact against a bearish reading of the share slide is that it has not touched the base: through the 2026 shock, existing households bought slightly more, resisted trading down, and retailers added distribution [33]. Only trial is contested, and trial is a function of price gap the company says it can manage geography by geography. What would change the read in either direction is observable: re-disclosure and stabilization of pasture-raised share, with the premium to other outdoor-access brands holding as price gaps narrow, would confirm the moat protects pricing; continued silence on share and a premium that has to keep falling to hold volume would say Cal-Maine and private label are turning a differentiated brand into a commoditizing one.